Bioengineering aims to improve targeted cancer therapies by enhancing drug delivery, boosting immune responses, and refining surgical techniques. The field is highly interdisciplinary, merging ...
Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback